FDA Import Refusal SCS-5846869-2/10002/1 — Dexlevo Inc

Dexlevo Inc — FEI 3032813480

The FDA refused shipment SCS-5846869-2/10002/1 from Dexlevo Inc (South Korea) on Jul 24, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 471,475 This firm has 3 other import refusals on record.

Refusal Details

Date
Jul 24, 2026
Country
South Korea
Product Category
Drugs and Biologics
Product Code
66VIK99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
471,475

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.